Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.

Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA.

Science. 2015 Feb 27;347(6225):995-8. doi: 10.1126/science.1258758.

2.

Virology. Delineating Ebola entry.

Falzarano D, Feldmann H.

Science. 2015 Feb 27;347(6225):947-8. doi: 10.1126/science.aaa8121. No abstract available.

PMID:
25722396
3.

Small molecule inhibitors of ebola virus infection.

Picazo E, Giordanetto F.

Drug Discov Today. 2015 Feb;20(2):277-86. doi: 10.1016/j.drudis.2014.12.010. Epub 2014 Dec 19. Review.

PMID:
25532798
4.

Teicoplanin inhibits Ebola pseudovirus infection in cell culture.

Wang Y, Cui R, Li G, Gao Q, Yuan S, Altmeyer R, Zou G.

Antiviral Res. 2016 Jan;125:1-7. doi: 10.1016/j.antiviral.2015.11.003. Epub 2015 Nov 14.

PMID:
26585243
5.

Development of therapeutics for treatment of Ebola virus infection.

Li H, Ying T, Yu F, Lu L, Jiang S.

Microbes Infect. 2015 Feb;17(2):109-17. doi: 10.1016/j.micinf.2014.11.012. Epub 2014 Dec 11. Review.

PMID:
25498866
6.

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.

Zhang X, Ao Z, Bello A, Ran X, Liu S, Wigle J, Kobinger G, Yao X.

Antiviral Res. 2016 Mar;127:20-31. doi: 10.1016/j.antiviral.2016.01.001. Epub 2016 Jan 9.

PMID:
26778707
7.

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.

J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.

8.

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.

Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, Becker S, Schnierle BS.

Virol J. 2016 Aug 31;13:149. doi: 10.1186/s12985-016-0607-2.

9.

Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.

Cui Q, Cheng H, Xiong R, Zhang G, Du R, Anantpadma M, Davey RA, Rong L.

Viruses. 2018 Nov 30;10(12). pii: E678. doi: 10.3390/v10120678.

10.

Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.

Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J.

Nature. 2011 Aug 24;477(7364):344-8. doi: 10.1038/nature10380.

11.

FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, Hoffstrom BG, Dewald LE, Schornberg KL, Scully C, Lehár J, Hensley LE, White JM, Olinger GG.

Sci Transl Med. 2013 Jun 19;5(190):190ra79. doi: 10.1126/scitranslmed.3005471.

12.

Novel Small Molecule Entry Inhibitors of Ebola Virus.

Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S425-34. doi: 10.1093/infdis/jiv223. Epub 2015 Jul 22.

13.

Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.

Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM.

PLoS One. 2013;8(2):e56265. doi: 10.1371/journal.pone.0056265. Epub 2013 Feb 18. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/76780c06-ac81-48a3-8cce-509da6858fe5.

14.

Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.

Beck S, Henß L, Weidner T, Herrmann J, Müller R, Chao YK, Grimm C, Weber C, Sliva K, Schnierle BS.

Antiviral Res. 2016 Aug;132:85-91. doi: 10.1016/j.antiviral.2016.05.017. Epub 2016 May 27.

PMID:
27241689
15.

Interferon-γ Inhibits Ebola Virus Infection.

Rhein BA, Powers LS, Rogers K, Anantpadma M, Singh BK, Sakurai Y, Bair T, Miller-Hunt C, Sinn P, Davey RA, Monick MM, Maury W.

PLoS Pathog. 2015 Nov 12;11(11):e1005263. doi: 10.1371/journal.ppat.1005263. eCollection 2015.

16.

The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.

Wu W, Liu S.

Curr Top Med Chem. 2017;17(3):361-370. Review.

PMID:
27572081
17.

Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.

Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L.

Antiviral Res. 2017 Sep;145:24-32. doi: 10.1016/j.antiviral.2017.06.015. Epub 2017 Jun 20.

18.

Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.

Nelson EA, Barnes AB, Wiehle RD, Fontenot GK, Hoenen T, White JM.

Viruses. 2016 Aug 2;8(8). pii: E206. doi: 10.3390/v8080206.

19.

Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.

Salata C, Baritussio A, Munegato D, Calistri A, Ha HR, Bigler L, Fabris F, Parolin C, Palù G, Mirazimi A.

Pathog Dis. 2015 Jul;73(5). pii: ftv032. doi: 10.1093/femspd/ftv032. Epub 2015 Apr 30.

PMID:
25933611
20.

Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.

Schafer A, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L.

Curr Med Chem. 2018;25(38):5177-5190. doi: 10.2174/0929867324666171010141416. Review.

PMID:
29032747

Supplemental Content

Support Center